Cargando…
The impact of universal access to direct-acting antiviral therapy on the hepatitis C cascade of care among individuals attending primary and community health services
BACKGROUND: Hepatitis C elimination will require widespread access to treatment and responses at the health-service level to increase testing among populations at risk. We explored changes in hepatitis C testing and the cascade of care before and after the introduction of direct-acting antiviral tre...
Autores principales: | Traeger, Michael W., Pedrana, Alisa E., van Santen, Daniela K., Doyle, Joseph S., Howell, Jessica, Thompson, Alexander J., El-Hayek, Carol, Asselin, Jason, Polkinghorne, Victoria, Membrey, Dean, Bramwell, Fran, Carter, Allison, Guy, Rebecca, Stoové, Mark A., Hellard, Margaret E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326180/ https://www.ncbi.nlm.nih.gov/pubmed/32603349 http://dx.doi.org/10.1371/journal.pone.0235445 |
Ejemplares similares
-
Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019 – CORRIGENDUM
por: Lee Wilkinson, Anna, et al.
Publicado: (2022) -
Impact of COVID‐19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs
por: Traeger, Michael W., et al.
Publicado: (2022) -
Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019
por: Lee Wilkinson, Anna, et al.
Publicado: (2021) -
Assessment of service refinement and its impact on repeat HIV testing by client's access to Australia's universal healthcare system: a retrospective cohort study
por: Ryan, Kathleen E, et al.
Publicado: (2019) -
Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study
por: Scott, Dr Nick, et al.
Publicado: (2021)